IN190831B - - Google Patents

Info

Publication number
IN190831B
IN190831B IN453DE1999A IN190831B IN 190831 B IN190831 B IN 190831B IN 453DE1999 A IN453DE1999 A IN 453DE1999A IN 190831 B IN190831 B IN 190831B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Jitendra Krishan Somani
Indu Bhushan
Himadrisen
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN453DE1999 priority Critical patent/IN190831B/en
Priority to US09/366,986 priority patent/US6346530B1/en
Priority to PT00909562T priority patent/PT1165051E/pt
Priority to CA002366617A priority patent/CA2366617A1/en
Priority to EP00909562A priority patent/EP1165051B1/en
Priority to ES00909562T priority patent/ES2202069T3/es
Priority to AU31843/00A priority patent/AU3184300A/en
Priority to PCT/IB2000/000292 priority patent/WO2000056286A1/en
Priority to BR0009177-4A priority patent/BR0009177A/pt
Priority to AT00909562T priority patent/ATE244560T1/de
Priority to US09/642,402 priority patent/US6323193B1/en
Priority to ZA200107718A priority patent/ZA200107718B/en
Priority to HK02104843.9A priority patent/HK1043540B/zh
Publication of IN190831B publication Critical patent/IN190831B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
IN453DE1999 1999-03-19 1999-03-19 IN190831B (ja)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IN453DE1999 IN190831B (ja) 1999-03-19 1999-03-19
US09/366,986 US6346530B1 (en) 1999-03-19 1999-08-04 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
PT00909562T PT1165051E (pt) 1999-03-19 2000-03-17 Processo para a preparacao de uma forma de dosagem oral biodisponivel de cefuroxima axetil
CA002366617A CA2366617A1 (en) 1999-03-19 2000-03-17 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
EP00909562A EP1165051B1 (en) 1999-03-19 2000-03-17 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
ES00909562T ES2202069T3 (es) 1999-03-19 2000-03-17 Procedimiento para la preparacion de una forma de dosificacion oral biodisponible de axetil cefuroxima.
AU31843/00A AU3184300A (en) 1999-03-19 2000-03-17 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
PCT/IB2000/000292 WO2000056286A1 (en) 1999-03-19 2000-03-17 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
BR0009177-4A BR0009177A (pt) 1999-03-19 2000-03-17 Processo para preparação de uma forma de dosagem oral biodisponìvel de axetil cefuroxima
AT00909562T ATE244560T1 (de) 1999-03-19 2000-03-17 Verfahren zur herstellung einer bioverfügbaren oralen darreichungsform von cefuroxim-axetil
US09/642,402 US6323193B1 (en) 1999-03-19 2000-08-21 Bioavailable oral dosage form of cefuroxime axetil
ZA200107718A ZA200107718B (en) 1999-03-19 2001-09-18 Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil.
HK02104843.9A HK1043540B (zh) 1999-03-19 2002-06-28 製備生物可利用的頭孢呋肟酯口服劑型的方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN453DE1999 IN190831B (ja) 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
IN190831B true IN190831B (ja) 2003-08-23

Family

ID=11089857

Family Applications (1)

Application Number Title Priority Date Filing Date
IN453DE1999 IN190831B (ja) 1999-03-19 1999-03-19

Country Status (3)

Country Link
US (1) US6346530B1 (ja)
IN (1) IN190831B (ja)
ZA (1) ZA200107718B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
US8900637B2 (en) 2005-12-02 2014-12-02 Lupin Limited Stable taste masked formulations of cephalosporins
CN102697747A (zh) * 2012-06-13 2012-10-03 广州南新制药有限公司 一种头孢呋辛酯的分散片

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1094545A (en) 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
NZ299077A (en) * 1996-07-26 1998-06-26 Apotex Inc Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf
IN186539B (ja) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
US6346530B1 (en) 2002-02-12
ZA200107718B (en) 2002-05-09

Similar Documents

Publication Publication Date Title
BE2018C020I2 (ja)
BE2016C007I2 (ja)
BE2015C057I2 (ja)
BE2013C051I2 (ja)
JP2002524782A5 (ja)
BRPI0017527B8 (ja)
JP2002524271A5 (ja)
JP2002533034A5 (ja)
JP2002527288A5 (ja)
JP2002529146A5 (ja)
BRPI0001672A2 (ja)
JP2002509275A5 (ja)
JP2002525925A5 (ja)
BRPI0001542A2 (ja)
JP2002522742A5 (ja)
BRPI0012675B8 (ja)
BRPI0017522A2 (ja)
IN190831B (ja)
JP2002530548A5 (ja)
BRMU7902607U2 (ja)
ECSDI990540S (ja)
IN190697B (ja)
CN3098433S (ja)
BY5467C1 (ja)
CN3098432S (ja)